Island Pharmaceuticals doses second cohort of subjects in ISLA-101 Single Ascending Dose study

Island Pharmaceuticals Ltd (ASX:ILA) has now dosed all eight subjects in the second cohort of its ISLA-101 Single Ascending Dose (SAD) study. ISLA-101 is a...

Related Keywords

Sydney ,New South Wales ,Australia ,David Foster ,Island Pharmaceuticals ,Scientia Clinical Research ,Contract Research Organisation ,Safety Review Committee ,Island Pharmaceuticals Ltd ,Drug Development ,Ascending Dose ,Single Ascending Dose ,Beyond Drug ,